February 2019 Briefing – Pathology

Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2019. This roundup includes the latest research news from journal articles, as […]

Here are what the editors at HealthDay consider to be the most important developments in Pathology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Performance Improvement Sustained After DBT Adoption

THURSDAY, Feb. 28, 2019 (HealthDay News) — Performance improvements after adoption of digital breast tomosynthesis (DBT) relative to digital mammography (DM) performance have been sustained, regardless of DBT volume, according to a study published online Feb. 26 in Radiology.

Abstract/Full Text (subscription or payment may be required)

Achievement of Targets in T2DM Varies by Season

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — There is seasonal variation in achievement of the guideline targets for hemoglobin A1c (HbA1c), blood pressure (BP), and low-density lipoprotein (LDL) cholesterol among persons with type 2 diabetes mellitus (T2DM), according to a study published online Feb. 22 in Diabetes Care.

Abstract/Full Text (subscription or payment may be required)

Adjuvant Tx for Early Testicular Cancer Does Not Harm Sperm

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — For clinical stage I testicular cancer (TC) patients, adjuvant treatment after orchiectomy has no long-term significant effect on sperm production, according to a study published online Feb. 25 in the Annals of Oncology.

Abstract/Full Text

Decline Observed in HPV Type 16/18 Cervical Precancers in U.S.

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to 2014, according to a study published online Feb. 21 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract/Full Text (subscription or payment may be required)

Single-Application FIT Moderately Sensitive, Specific for CRC

MONDAY, Feb. 25, 2019 (HealthDay News) — Single-application fecal immunochemical tests (FITs) have moderate-to-high sensitivity and specificity for colorectal cancer (CRC), according to a review published online Feb. 26 in the Annals of Internal Medicine.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

2014 to 2017 Saw Improvement in Burnout for U.S. Physicians

MONDAY, Feb. 25, 2019 (HealthDay News) — From 2014 to 2017, there was an improvement in burnout and satisfaction with work-life integration among U.S. physicians, according to a study published online Feb. 22 in the Mayo Clinic Proceedings.

Abstract/Full Text

Incidence of Acute Myocardial Infarctions Up Among Young Women

1 | 2 | 3 | 4 | 5 | 6 | 7
Page 1 of 7
Next »